[8-K] METLIFE INC Reports Material Event
MetLife disclosed receipt of an unsolicited mini-tender offer from Potemkin Limited to buy up to 10,000 shares of MetLife common stock at $53.00 per share, which the filing states is about 34.42% below MetLife's closing price of $80.82 on September 12, 2025. The shares subject to the offer equal approximately 0.00002% of MetLife's outstanding common stock as of August 31, 2025. MetLife does not endorse the offer, is not associated with Potemkin, and on September 15, 2025 issued a news release advising shareholders not to tender and explaining that shareholders who already tendered may withdraw prior to the offer's scheduled expiration at 5:00 p.m. ET on October 7, 2025. The news release is attached as Exhibit 99.1 and incorporated by reference.
MetLife ha comunicato di aver ricevuto un'offerta di mini-tender non sollecita da parte di Potemkin Limited per l'acquisto di fino a 10.000 azioni comuni MetLife a $53.00 per azione, che, secondo la documentazione, è circa 34,42% sotto la chiusura di MetLife di $80.82 il 12 settembre 2025. Le azioni soggette all'offerta rappresentano circa 0,00002% delle azioni ordinarie in circolazione al 31 agosto 2025. MetLife non sostiene l'offerta, non è associata a Potemkin e, il 15 settembre 2025, ha emesso un comunicato stampa agli azionisti in cui si invita a non offrire e si spiega che gli azionisti che hanno già offerto possono ritirare prima della scadenza prevista alle 17:00 ET del 7 ottobre 2025. Il comunicato è allegato come Exhibit 99.1 e incorporato per riferimento.
MetLife informó haber recibido una oferta no solicitada de mini-tender por parte de Potemkin Limited para comprar hasta 10,000 acciones de las acciones comunes de MetLife a $53.00 por acción, lo cual la presentación indica que representa aproximadamente un 34,42% menos que el cierre de MetLife de $80.82 el 12 de septiembre de 2025. Las acciones sujetas a la oferta representan aproximadamente 0.00002% del capital social común en circulación a 31 de agosto de 2025. MetLife no respalda la oferta, no está asociado con Potemkin y, el 15 de septiembre de 2025, emitió un comunicado a los accionistas solicitando no tender y explicando que los accionistas que ya hayan tenderizado pueden retirar antes de la fecha límite prevista a las 5:00 p.m. ET del 7 de octubre de 2025. El comunicado se adjunta como Exhibit 99.1 y se incorpora por referencia.
MetLife는 Potemkin Limited가 최대 10,000주의 MetLife 보통주를 주당 $53.00에 매수하는 비자발적 미니-텐더 제안을 받았다고 공시했습니다. 이는 공시문에 따르면 2025년 9월 12일 MetLife의 종가 $80.82에서 약 34.42% 하락한 수준입니다. 제안 대상 주식은 2025년 8월 31일 기준 MetLife의 발행 보통주 중 약 0.00002%를 차지합니다. MetLife는 이 제안을 지지하지 않으며 Potemkin과 관련이 없으며, 2025년 9월 15일 주주들에게 매입 제의에 동의하지 말 것을 권고하는 보도자료를 발표했고 이미 매수한 주주는 2025년 10월 7일 5:00 p.m. ET까지 철회할 수 있다고 설명했습니다. 보도자료는 Exhibit 99.1로 첨부되었고 참조에 포함되어 있습니다.
MetLife a annoncé avoir reçu une offre inattendue de mini-tender de Potemkin Limited pour acheter jusqu'à 10 000 actions des actions ordinaires MetLife à $53,00 par action, dont le dossier indique qu'y correspond environ 34,42% de moins que le cours de clôture de MetLife de $80,82 au 12 septembre 2025. Les actions visées par l'offre représentent environ 0,00002% des actions ordinaires en circulation au 31 août 2025. MetLife ne soutient pas l'offre, n’est pas associée à Potemkin et, le 15 septembre 2025, a publié un communiqué aux actionnaires les invitant à ne pas répondre à l’offre et expliquant que les actionnaires ayant déjà répondu peuvent retirer leur offre avant l'échéance prévue à 17h00 ET le 7 octobre 2025. Le communiqué est joint en tant qu'Exhibit 99.1 et est incorporé par référence.
MetLife hat den Erhalt eines unaufgeforderten Mini-Tender-Angebots von Potemkin Limited bekannt gegeben, bis zu 10.000 Aktien der MetLife-Stammaktien zu $53,00 pro Aktie zu kaufen. Laut der Einreichung liegt dies etwa 34,42% unter dem Schlusskurs von MetLife von $80,82 am 12. September 2025. Die Aktien, die Gegenstand des Angebots sind, entsprechen ca. 0,00002% der im August 2025 ausgegebenen Stammaktien. MetLife unterstützt das Angebot nicht, ist nicht mit Potemkin verbunden und hat am 15. September 2025 eine Mitteilung veröffentlicht, in der Aktionäre aufgefordert werden, nicht zu offerieren, und erklärt, dass Aktionäre, die bereits angeboten haben, vor Ablauf am 17:00 Uhr ET am 7. Oktober 2025 widerrufen können. Die Mitteilung ist als Exhibit 99.1 beigefügt und wird durch Verweis einbezogen.
MetLife أعلنت عن تلقيها عرض تلمس-cap غير مطلوب من Potemkin Limited لشراء ما يصل إلى 10,000 سهم من أسهم MetLife العادية مقابل $53.00 للسهم، وهو ما تذكر الوثيقة أنه يساوي نحو 34.42% أقل من سعر إغلاق MetLife البالغ $80.82 في 12 سبتمبر 2025. تمثل الأسهم الخاضعة للعرض نحو 0.00002% من إجمالي الأسهم العادية المتداولة حتى 31 أغسطس 2025. لا تؤيد MetLife العرض، وليست مرتبطة بـ Potemkin، وفي 15 سبتمبر 2025 أصدرت بياناً صحفياً للمساهمين تطلب فيه عدم تقديم عروض وتشرح أن المساهمين الذين قدَّموا عروضهم يمكنهم سحبها قبل انتهاء العرض في الساعة 5:00 مساءً بتوقيت شرق الولايات المتحدة في 7 أكتوبر 2025. البيان مرفق كـ Exhibit 99.1 وُيُدمج بالمرجعية.
MetLife 宣布收到来自 Potemkin Limited 的一项非受邀小型Tender要约，拟以每股 $53.00 购买至多 10,000 股 MetLife 普通股，文件称该价格约比 MetLife 于 2025 年 9 月 12 日的收盘价 $80.82 低 34.42%。该要约所涉及的股份约占 MetLife 截至 2025 年 8 月 31 日在外流通的普通股的 0.00002%。MetLife 不支持该要约，与 Potemkin 无关联，且在 2025 年 9 月 15 日发布新闻稿，敦促股东不要参与要约，并解释已参与认购的股东可在要约预计到期前撤回，截止时间为 美东时间 2025 年 10 月 7 日 17:00。新闻稿作为 Exhibit 99.1 附件并被引用。
- Company disclosure and shareholder advisory issued: MetLife publicly informed shareholders and attached a news release (Exhibit 99.1).
- Offer size is negligible: Potemkin's offer covers only 10,000 shares, about 0.00002% of outstanding common stock.
- Unsolicited mini-tender priced well below market: Offer price of $53.00 is approximately 34.42% below the $80.82 closing price on September 12, 2025.
- Potential for shareholder harm if unaware: The filing implies shareholders who tendered may need to withdraw before the stated expiration to avoid an unfavorable sale.
Insights
TL;DR: A low-priced unsolicited mini-tender targets a de minimis portion of MetLife shares; company issued a warning to shareholders.
Potemkin's offer at $53.00 per share is stated as materially below the recent market close ($80.82), creating a strong price differential that could tempt uninformed holders. The filing confirms the offer covers only 10,000 shares, about 0.00002% of outstanding stock, suggesting negligible direct balance-sheet or ownership impact. MetLife's public advisory and the attached news release provide the procedural remedy for tender withdrawals prior to the stated expiration.
TL;DR: MetLife followed standard governance practice by disclaiming association and formally warning shareholders.
The Form 8-K documents the company distancing itself from Potemkin and proactively communicating to shareholders not to tender, consistent with good issuer communication for unsolicited offers. The disclosure includes concrete mechanics and timelines (withdrawal instructions per the offer documents; expiration at 5:00 p.m. ET on October 7, 2025), which helps protect shareholder interests without suggesting any systemic governance failure. The extremely small offer size implies limited governance or control risk.
MetLife ha comunicato di aver ricevuto un'offerta di mini-tender non sollecita da parte di Potemkin Limited per l'acquisto di fino a 10.000 azioni comuni MetLife a $53.00 per azione, che, secondo la documentazione, è circa 34,42% sotto la chiusura di MetLife di $80.82 il 12 settembre 2025. Le azioni soggette all'offerta rappresentano circa 0,00002% delle azioni ordinarie in circolazione al 31 agosto 2025. MetLife non sostiene l'offerta, non è associata a Potemkin e, il 15 settembre 2025, ha emesso un comunicato stampa agli azionisti in cui si invita a non offrire e si spiega che gli azionisti che hanno già offerto possono ritirare prima della scadenza prevista alle 17:00 ET del 7 ottobre 2025. Il comunicato è allegato come Exhibit 99.1 e incorporato per riferimento.
MetLife informó haber recibido una oferta no solicitada de mini-tender por parte de Potemkin Limited para comprar hasta 10,000 acciones de las acciones comunes de MetLife a $53.00 por acción, lo cual la presentación indica que representa aproximadamente un 34,42% menos que el cierre de MetLife de $80.82 el 12 de septiembre de 2025. Las acciones sujetas a la oferta representan aproximadamente 0.00002% del capital social común en circulación a 31 de agosto de 2025. MetLife no respalda la oferta, no está asociado con Potemkin y, el 15 de septiembre de 2025, emitió un comunicado a los accionistas solicitando no tender y explicando que los accionistas que ya hayan tenderizado pueden retirar antes de la fecha límite prevista a las 5:00 p.m. ET del 7 de octubre de 2025. El comunicado se adjunta como Exhibit 99.1 y se incorpora por referencia.
MetLife는 Potemkin Limited가 최대 10,000주의 MetLife 보통주를 주당 $53.00에 매수하는 비자발적 미니-텐더 제안을 받았다고 공시했습니다. 이는 공시문에 따르면 2025년 9월 12일 MetLife의 종가 $80.82에서 약 34.42% 하락한 수준입니다. 제안 대상 주식은 2025년 8월 31일 기준 MetLife의 발행 보통주 중 약 0.00002%를 차지합니다. MetLife는 이 제안을 지지하지 않으며 Potemkin과 관련이 없으며, 2025년 9월 15일 주주들에게 매입 제의에 동의하지 말 것을 권고하는 보도자료를 발표했고 이미 매수한 주주는 2025년 10월 7일 5:00 p.m. ET까지 철회할 수 있다고 설명했습니다. 보도자료는 Exhibit 99.1로 첨부되었고 참조에 포함되어 있습니다.
MetLife a annoncé avoir reçu une offre inattendue de mini-tender de Potemkin Limited pour acheter jusqu'à 10 000 actions des actions ordinaires MetLife à $53,00 par action, dont le dossier indique qu'y correspond environ 34,42% de moins que le cours de clôture de MetLife de $80,82 au 12 septembre 2025. Les actions visées par l'offre représentent environ 0,00002% des actions ordinaires en circulation au 31 août 2025. MetLife ne soutient pas l'offre, n’est pas associée à Potemkin et, le 15 septembre 2025, a publié un communiqué aux actionnaires les invitant à ne pas répondre à l’offre et expliquant que les actionnaires ayant déjà répondu peuvent retirer leur offre avant l'échéance prévue à 17h00 ET le 7 octobre 2025. Le communiqué est joint en tant qu'Exhibit 99.1 et est incorporé par référence.
MetLife hat den Erhalt eines unaufgeforderten Mini-Tender-Angebots von Potemkin Limited bekannt gegeben, bis zu 10.000 Aktien der MetLife-Stammaktien zu $53,00 pro Aktie zu kaufen. Laut der Einreichung liegt dies etwa 34,42% unter dem Schlusskurs von MetLife von $80,82 am 12. September 2025. Die Aktien, die Gegenstand des Angebots sind, entsprechen ca. 0,00002% der im August 2025 ausgegebenen Stammaktien. MetLife unterstützt das Angebot nicht, ist nicht mit Potemkin verbunden und hat am 15. September 2025 eine Mitteilung veröffentlicht, in der Aktionäre aufgefordert werden, nicht zu offerieren, und erklärt, dass Aktionäre, die bereits angeboten haben, vor Ablauf am 17:00 Uhr ET am 7. Oktober 2025 widerrufen können. Die Mitteilung ist als Exhibit 99.1 beigefügt und wird durch Verweis einbezogen.
FAQ
What is Potemkin Limited's offer for MET stock?
How does Potemkin's offer price compare to MetLife's recent market price?
What portion of MetLife's outstanding shares does the offer represent?
What action did MetLife take in response to the mini-tender?
Can shareholders withdraw shares already tendered to Potemkin?
When does Potemkin's offer expire?
